Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 8 (August)

1. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas.
   Cancer Sci, 96(7): 403-8. [Abstract] [Full-text]
2. Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells.
   Cancer Sci, 96(7): 387-93. [Abstract] [Full-text]
3. Major upper gastrointestinal surgery is associated with an antigen-dependent proinflammatory T cell response.
   Br J Surg, 92(8): 989-95. [Abstract] [Full-text]
4. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
   J Histochem Cytochem, 53(8): 989-95. [Abstract] [Full-text]
5. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
   Cancer Res, 65(15): 6967-75. [Abstract] [Full-text]
6. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis.
   Int J Cancer, 116(6): 925-33. [Abstract] [Full-text]
7. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.
   Br J Cancer, 93(3): 319-30. [Abstract] [Full-text]
8. Genome-wide aberrations in pancreatic adenocarcinoma.
   Cancer Genet Cytogenet, 161(1): 36-50. [Abstract] [Full-text]
9. Probability of pancreatic cancer following diabetes: a population-based study.
   Gastroenterology, 129(2): 504-11. [Abstract] [Full-text]
10. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
    Int J Cancer, 117(1): 160-5. [Abstract] [Full-text]
11. Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation.
    Pancreatology, 5(4): 330-44. [Abstract] [Full-text]
12. Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors.
    Oncology, 68(2): 179-89. [Abstract] [Full-text]
13. An early phase II study of S-1 in patients with metastatic pancreatic cancer.
    Oncology, 68(2): 171-8. [Abstract] [Full-text]
14. A resected case of multiple intraductal papillary mucinous tumors of the pancreas with US-guided ductal branch-oriented partial pancreatectomy.
    Pancreatology, 5(4): 462-5. [Abstract] [Full-text]
15. Intraoperative radiotherapy for patients with carcinoma of the pancreas.
    Pancreatology, 5(4): 438-42. [Abstract] [Full-text]
16. Pancreatic juice cytology in IPMN of the pancreas.
    Pancreatology, 5(4): 416-21; discussion 421. [Abstract] [Full-text]
17. Pancreatic hepatocellular tumor.
    Pancreatology, 5(4): 410-5. [Abstract] [Full-text]
18. Effects of the antioxidative vitamins A, C and E on liver metastasis and intrametastatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters.
    Pancreatology, 5(4): 403-9. [Abstract] [Full-text]
19. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT.
    Pancreatology, 5(4): 398-402. [Abstract] [Full-text]
20. Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
    Pancreatology, 5(4): 470-4. [Abstract] [Full-text]
21. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer.
    Pancreatology, 5(4): 370-9. [Abstract] [Full-text]
22. The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored.
    Pancreatology, 5(4): 316-24; discussion 324. [Abstract] [Full-text]
23. Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines.
    Pancreatology, 5(4): 387-97. [Abstract] [Full-text]
24. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer.
    Pancreatology, 5(4): 361-9. [Abstract] [Full-text]
25. Current status of laparoscopic biliary bypass in the management of non-resectable peri-ampullary cancer.
    Pancreatology, 5(4): 325-9. [Abstract] [Full-text]
26. Increasing serum betahydroxybutyrate concentrations during the 72-hour fast: evidence against hyperinsulinemic hypoglycemia.
    J Clin Endocrinol Metab, 90(8): 4555-8. [Abstract] [Full-text]
27. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Oncology, 68(2): 97-106. [Abstract] [Full-text]
28. Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.
    Oncology, 68(4): 493-9. [Abstract] [Full-text]
29. Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.
    Oncology, 68(4): 432-7. [Abstract] [Full-text]
30. A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma.
    Oncology, 68(4): 299-305. [Abstract] [Full-text]
31. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
    Br J Cancer, 93(4): 441-9. [Abstract] [Full-text]
32. An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer.
    Am J Surg, 190(3): 406-11. [Abstract] [Full-text]
33. The potential of oncolytic virus therapy for pancreatic cancer.
    Cancer Gene Ther, 12(9): 725-36. [Abstract] [Full-text]
34. Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells.
    Cancer Lett, 227(2): 193-200. [Abstract] [Full-text]
35. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Cancer Lett, 227(2): 175-84. [Abstract] [Full-text]
36. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways.
    Biochem Biophys Res Commun, 335(3): 949-56. [Abstract] [Full-text]
37. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience.
    Radiology, 236(3): 1034-40. [Abstract] [Full-text]
38. Intraoperative gamma probe detection of lymph node recurrence of insulinoma.
    J Surg Oncol, 91(3): 209-11. [Abstract] [Full-text]
39. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy.
    Eur J Surg Oncol, 31(7): 768-73. [Abstract] [Full-text]
40. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
    Int J Cancer, 117(2): 234-40. [Abstract] [Full-text]
41. Mucinous cystadenocarcinoma of the pancreas in an adolescent with cystic fibrosis.
    Pediatr Dev Pathol, 8(3): 391-6. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.